Home » Newsletters » BioWorld Science

BioWorld Science

July 5, 1999

View Archived Issues

Gene that causes familial British dementia discovered

Onyvax and Erasmus University reach prostate cancer agreement

Cambridge Combinatorial to provide chemistry services to Pfizer

Pharming begins phase I development of human lactoferrin

FDA grants orphan drug designation for Ceresine in traumatic brain injury

CollaGenex signs marketing agreement for Periostat in Canada

Cerus initiates phase I allogeneic bone marrow transplant study

Amylin initiates phase II study of AC-2993 in type II diabetes

Novo Nordisk seeks approval for liquid GH in the U.S.

GW-420867X is a promising component of anti-HIV combination therapy

DAPD: another promising agent for combination therapy of HIV/AIDS

Howard Hughes researchers uncover mechanism of interferon resistance in HCV

Neuroprotectants in early development at Pharmacia & Upjohn

Thienopyrimidine inhibitors of PDE5 described by Merck KGaA

P&U studies compounds that intervene in the kynurenine metabolic pathway

Epimmune-Cytel merger complete; new company up and running

Astra (AstraZeneca) presents new agents for GI inflammatory disorders

Alsterpaullone is a potent CDK1/cyclin B inhibitor and antitumor agent

New compounds from Senju under evaluation for complications of diabetes

Antifungal triazoles patented by SS Pharm.

Fujisawa prepares new cephem antibiotics

Russian scientists test GVS-111 in preclinical assays

Renal allograft survival is prolonged by treatment with anti-CD4-idarubicin immunoconjugate

NCC-1048 is a novel neuronal calcium channel blocker with potential in cerebral ischemia

Stable HLE inhibitors with in vivo activity in lung hemorrhage model identified at Chinoin

Novel noncompetitive AMPA antagonist presented at European Congress of Pharmacology

Kissei seeks approval of amprenavir in Japan

Noncompetitive AMPA receptor antagonist emerges as development candidate for stroke, epilepsy, etc.

Second-generation PDE4 inhibitors highlighted at World Congress on Inflammation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...